Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 2 3Phase 3 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Psychological Well-Being 1Parasomnias 1Neoplasms 1Fatigue 1Breast Neoplasms 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Relaxation Therapy × Clear all
NCT01202851 2026-05-05

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
681 enrolled
Breast

Psychological Well-Being, Breast Neoplasms, Fatigue, Parasomnias

NCT00435474 2009-06-09

Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy

Rigshospitalet, Denmark

Phase 3 Completed
70 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡